1-161548543-A-T
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000569.8(FCGR3A):c.197T>A(p.Leu66His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0644 in 1,612,026 control chromosomes in the GnomAD database, including 732 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L66R) has been classified as Benign.
Frequency
Consequence
NM_000569.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCGR3A | NM_000569.8 | c.197T>A | p.Leu66His | missense_variant | 3/5 | ENST00000443193.6 | NP_000560.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCGR3A | ENST00000443193.6 | c.197T>A | p.Leu66His | missense_variant | 3/5 | 1 | NM_000569.8 | ENSP00000392047.2 | ||
ENSG00000289768 | ENST00000699402.1 | c.194T>A | p.Leu65His | missense_variant | 3/4 | ENSP00000514363.1 |
Frequencies
GnomAD3 genomes AF: 0.0505 AC: 7659AN: 151798Hom.: 100 Cov.: 38
GnomAD3 exomes AF: 0.0554 AC: 13908AN: 250992Hom.: 26 AF XY: 0.0567 AC XY: 7693AN XY: 135638
GnomAD4 exome AF: 0.0659 AC: 96231AN: 1460108Hom.: 632 Cov.: 125 AF XY: 0.0653 AC XY: 47469AN XY: 726392
GnomAD4 genome AF: 0.0504 AC: 7656AN: 151918Hom.: 100 Cov.: 38 AF XY: 0.0498 AC XY: 3698AN XY: 74260
ClinVar
Submissions by phenotype
Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity Pathogenic:1Uncertain:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2012 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | FCGR3A NM_1127593.1 exon 4 p.Leu66His (c.197T>A): This variant has been reported in the literature as homozygous in 3 individuals with recurrent infection, suggestive of NK cell defects (de Vries 1996 PMID:8874200, Jawahar 1996 PMID:8608639, Grier 2012 PMID:23006327, called c.230T>A p.Leu66His). This variant is present in 7.5% (9575/126258) of European alleles including 17 homozygotes in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs10127939). This variant is present in ClinVar (Variation ID:14828). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, although this variant is present at a high frequency in the general population, the presence of conflicting data on this variant suggests insufficient information for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: High frequency in the general population (5 homozygotes in ExAC), but homozygous change at this position has been reported in 3 individuals with NK cell deficiency. 2 probands had recurrent upper respiratory infections. In vitro study shows possible functional impact (PMID 23006327). - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at